Huang W, Hei Z, Huang W
Department of Anesthesia, First Hospital Affiliated to Sun Yat-sen University of Medical Sciences, Guangzhou 510080, China.
Zhonghua Yi Xue Za Zhi. 2001 Jun 25;81(12):737-9.
To study the perioperative changes of and anesthetic management for patient under orthotopic liver transplantation (OLT).
General anesthesia or general anesthesia combined with epidural block anesthesia was conducted. During the anhepatic phase, extracorporeal veno-venous bypass (EVVB) was used. Hemodynamics, respiratory function, blood gas, blood biochemistry, coagulation function, body temperature, blood glucose, urinary output and bleeding output were monitored during the operation. According to the characteristics of pre-anhepatic phase, anhepatic phase and neohepatic phases, corresponding anesthetic management measures were supplied.
(1) Forty-four patients tolerated the operation. One patient died of massive blood loss intraoperatively. 2 000 approximately 4 000 ml of blood was transfused to 29 patients, 4 000 approximately 6 000 ml to 7 patients and more than 6 000 ml to 8 patients. (2) During the anhepatic phase hemodynamics in 44 patients remained stable. However, in the fifteen minutes' primary stages of anhepatic phase and in neohepatic phase, transient circulatory instability occurred. Blood volume expansion was applied immediately and succeeded to correct the instability. (3) No patient, except one with massive blood loss showed obvious acid-base disturbance occurred during OLT. (4)The main electrolytic change during perioperative phase was hypocalcemia. (5) During the operation a marked change in body temperature took place. (6) Disturbance of coagulation function to a certain degree occurred. (7) The blood glucose level was higher than normal during OLT, and gradually decreased during the neohepatic phase.
Attention should be paid to the anesthetic management and monitoring during different phases of OLT. Appropriate treatment helps to keep the blood gas, blood biochemistry and coagulation function remain normal and stable. Use of EVVB during anhepatic phase can be helpful to keep hemodynamics stable and prevent obvious acidosis and hyperkalemia. Supplementation of coagulation factors, and proper use of hemostatic drugs and protamine to neutralize heparin were needed. Anti-rejection drugs were necessary during OLT.
研究原位肝移植(OLT)患者围手术期的变化及麻醉管理。
采用全身麻醉或全身麻醉联合硬膜外阻滞麻醉。在无肝期,使用体外静脉-静脉转流(EVVB)。术中监测血流动力学、呼吸功能、血气、血液生化、凝血功能、体温、血糖、尿量及出血量。根据肝前期、无肝期和新肝期的特点,采取相应的麻醉管理措施。
(1)44例患者耐受手术。1例患者术中死于大出血。29例患者输注约2000~4000ml血液,7例患者输注约4000~6000ml血液,8例患者输注超过6000ml血液。(2)44例患者在无肝期血流动力学保持稳定。然而,在无肝期开始的15分钟及新肝期,出现短暂循环不稳定。立即进行血容量扩充并成功纠正不稳定状态。(3)除1例大出血患者外,OLT期间无患者出现明显酸碱紊乱。(4)围手术期主要电解质变化为低钙血症。(5)术中体温发生明显变化。(6)出现一定程度的凝血功能障碍。(7)OLT期间血糖水平高于正常,在新肝期逐渐下降。
OLT不同阶段应重视麻醉管理和监测。适当的处理有助于保持血气、血液生化及凝血功能正常稳定。无肝期使用EVVB有助于维持血流动力学稳定,预防明显酸中毒和高钾血症。需要补充凝血因子,合理使用止血药物及鱼精蛋白中和肝素。OLT期间需要使用抗排斥药物。